ReferenceID 2549

Osthole Ameliorates Estrogen Deficiency-Induced Cognitive Impairment in Female Mice

Front Pharmacol

Loss of endogenous estrogen and dysregulation of the estrogen receptor signaling pathways are associated with an increase in risk for cognitive deficit and depression in women after menopause. Estrogen therapy for menopa

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final reference record.

Reference Id
2549
Evidence Id
19139
Core Evidence Id
19139
Source Reference Id
5103
Herb2 Reference Id
HBREF005900
Subject Paper Key
HBIN038387_34025413
Pubmed Id
34025413
Doi
10.3389/fphar.2021.641909
Paper Title
Osthole Ameliorates Estrogen Deficiency-Induced Cognitive Impairment in Female Mice
Paper Abstract
Loss of endogenous estrogen and dysregulation of the estrogen receptor signaling pathways are associated with an increase in risk for cognitive deficit and depression in women after menopause. Estrogen therapy for menopause increases the risk of breast and ovarian cancers, and stroke. Therefore, it is critical to find an alternate treatment for menopausal women. Osthole (OST), a coumarin, has been reported to have neuroprotective effects. This study examined whether OST improves ovariectomy (OVX)-induced cognitive impairment, and alleviates anxiety- and depression-like behaviors induced by OVX in mice. Adult female C57BL/6J mice were ovariectomized and then treated with OST at a dose of 30 mg/kg for 14 days. At the end of the treatment period, behavioral tests were used to evaluate spatial learning and memory, recognition memory, anxiety- and depression-like behaviors. A cohort of the mice were sacrificed after 14 days of OST treatment and their hippocampi were collected for measurement of the proteins of interest using western blot. OVX-induced alteration in the levels of proteins was accompanied by cognitive deficit, anxiety- and depression-like behaviors. OST treatment improved cognitive deficit, alleviated anxiety- and depression-like behaviors induced by OVX, and reversed OVX-induced alterations in the levels of synaptic proteins and ERalpha, BDNF, TrKB, p-CREB, p-Akt and Rac1 in the hippocampus. Therefore, reversal of OVX-induced decrease in the levels of hippocampal proteins by OST might contribute to the effects of OST on improving cognitive deficit and alleviating anxiety- and depression-like behaviors induced by OVX.
Journal
Front Pharmacol
Publish Year
2021
Experiment Subject
mouse; women
Experiment Type
Animal Experiment
Phenotype Related
Stroke; Cognitive Impairment; Cognitive Deficit; Depression; Breast And Ovarian Cancers; Anxiety- And Depression
Paper Title Cn
Paper Title En
Osthole Ameliorates Estrogen Deficiency-Induced Cognitive Impairment in Female Mice
Bilingual Status
semi_complete